PCSK9 and breast carcinoma: Furthermore, PCSK9 genetic variants known to result in elevated LDL‐C levels were associated with increased breast cancer risk overall (per SD, OR [95% CI]: 1.10 [1.02–1.19]; p = 0.014).67